Acute Ischemic Stroke |
 | Different Strokes:Addressing Real Clinician Questions and Controversies Surrounding Acute Management of Ischemic Stroke |
Alzheimer's Disease |
 | Understanding the Fine PrintThe Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease |
 | From the Ground UpEvolving Strategies for the Identification and Team-Based Management of Patients with Early-Stage Alzheimer's Disease Neurobiology |
 | From Critique to ConsensusQuantifying & Clarifying Expert Perspectives on the Future Management of Alzheimer's Disease |
 | Why Now?The New Paradigm and Rising Role of Nuclear Medicine in Alzheimer’s Disease |
Bipolar Depression |
 | Out of the Dark, Into the LightIlluminating Modern Strategies for the Detection and Treatment of Bipolar Depression |
Epilepsy |
 | Broadening the Treatment HorizonExamining the Expanding Roles of New Therapies in Epilepsy Management |
 | Are We There Yet?New Agents and Foundational Shifts Toward Precision Medicine in Epilepsy |
 | The Path of Least ResistanceNew Agents and Emerging Strategies for Managing Childhood-Onset and Refractory Epilepsies |
Idiopathic Hypersomnia and Narcolepsy |
 | Hidden in Plan SightExpert Strategies for Eliciting a History of and Effectively Managing Cataplexy in Patients with Narcolepsy Type-1 |
 | "Wake Up" - An Adaptation of a Virtual Grand Rounds SeriesModern Strategies to Recognize and Combat Sleepiness in Narcolepsy and Idiopathic Hypersomnia |
Major Depressive Disorder |
 | Finding Something in NothingPatient-Centered Approaches to Resolve Emotional Blunting in Major Depressive Disorder |
Migraine |
 | Conversations in NeurologyNew Agents And Strategies For Migraine and Related Headache Disorders Edition |
 | Networks in NeurologyNew Agents and Strategies for Migraine |
Multiple Sclerosis |
 | Across the SpectrumTransforming the Detection and Management of Disease State Transitions Across the Spectrum of Multiple Sclerosis |
 | Overburdened, UndertreatedDevelopments in the Patient-Centered Management of Spasticity in Multiple Sclerosis |
 | Battle of the Biomarkers: Assessing Key Factors in Prognosis, Monitoring, and Therapeutic Decision-Making for Disease Worsening in Multiple Sclerosis |
 | How Do I...?An Integrated CME Activity Comparing the Clinical Decisions of MS Specialists and General Neurologists |
 | Networks in NeurologyExpert Approaches to New Agents and Strategies for MS |
 | Calibrating COVIDThe Interplay of Disease Modifying Therapy and Vaccination in Patients with MS |
 | Multiple Sclerosis ManagementShedding Light on the Patient Perspective - A CMSC Satellite Symposium |
 | Devil in the DetailsAn Expert Guide to Modern Multiple Sclerosis Practices |
 | What Can Biomarkers Tell Us?Modern Tools to Assist Navigating Prognosis, Monitoring, and Therapeutic Decision-Making in the Long-Term Management of Multiple Sclerosis |
 | Over-Impacted, Under-RepresentedAddressing Health Disparities in Multiple Sclerosis |
 | Evolution of Progression:An Expert Forum on Advancements in Monitoring and Treating Multiple Sclerosis |
Myasthenia Gravis |
 | Inside Myasthenia GravisWhere Providers and Patients Diverge on Defining Treatment Success |
Neuromyelitis Optica Spectrum Disorder |
 | Deciphering Neuromyelitis Optica Spectrum DisorderAddressing Real Clinician Questions Concerning Diagnosis and Management |
 | A Deeper Look at Neuromyelitis Optica Spectrum Disorder:A Glimpse Onto the Clinic Floor with Specialists |
 | Reshaping the ParadigmAn ACTRIMS-ECTRIMS Satellite Symposium |
 | Critical and ContestedA High-Yield Educational Activity Addressing Difficult and Valuable Topics in Neuromyelitis Optica Spectrum Disorders |
Parkinson's Disease |
 | On Target with “OFF” Therapies:An Exploration of New Agents and Strategies for Parkinson’s Disease |
 | The Next LevelIncorporating Device-Aided Therapies into Parkinson’s Disease Management |
Pompe Disease |
 | The Survival EraEvolving Strategies for the Care of Patients with Pompe Disease |
Spasticity and Dystonia |
 | Unlocking MovementAddressing Key Challenges and Strategic Solutions in the Use of Botulinum Toxin for Spasticity and Dystonia |
Spinal Muscular Atrophy |
 | The New Picture of Spinal Muscular AtrophyTesting, Treatments, and Transitions |